Earth Science Te Stock Price, News & Analysis

Earth Science Tech (OTC: ETST) has significantly enhanced its share repurchase program, increasing the total authorization to $10 million and extending it through December 31, 2027. Since the program's inception in January 2024, ETST has already invested $1.83 million to repurchase 20.83 million shares.

The company currently has a remaining authorization of $8.17 million for future share repurchases. The program allows for discretionary repurchases through open market or private transactions, subject to market conditions and other factors, and can be suspended or discontinued at any time.

Earth Science Tech (OTC:ETST) announced its Board of Directors has approved a reduction in authorized common stock from 350 million to 300 million shares. The company currently has approximately 294.3 million shares outstanding.

CEO Giorgio R. Saumat emphasized that this strategic decision reflects the Board's confidence in the company's trajectory and demonstrates their commitment to preventing unnecessary shareholder dilution while protecting long-term shareholder value.

Earth Science Tech (OTC: ETST) reported significant growth in its first fiscal quarter ended June 30, 2025. The company's total assets increased 61% to $7.69 million, while revenue reached $8.7 million, up from $8.5 million year-over-year.

During the quarter, ETST executed several strategic acquisitions, including 100% acquisition of Las Villas Health Care and DOConsultation, along with 80% ownership of Magnefuse and Alicat (MagneChef Portfolio). The company reduced its outstanding shares by 4.78% to 294.3 million shares and maintained a cash position of $0.88 million after funding acquisitions.

Post-quarter developments include joining the OTCID Tier, expanding MisterMeds operations in Texas, and initiating Avenvi's first residential development project.

Earth Science Tech (OTC: ETST) has announced its qualification and listing on the new OTCID tier of OTC Markets, a designation that recognizes companies meeting enhanced disclosure, transparency, and compliance standards. The Company, which operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, views this achievement as a reflection of its commitment to corporate governance and investor communication.

CEO and Chairman Giorgio R. Saumat highlighted the company's turnaround over the past two years. The company expects this new designation to enhance investor confidence and support its growth initiatives.

Earth Science Tech (OTC: ETST) has reported exceptional financial results for the fiscal year ended March 31, 2025. The company achieved significant growth across all key metrics, with revenue reaching $33.1 million, representing a remarkable 177.05% increase year-over-year.

The company's performance showed substantial improvements in profitability, with net profit surging by 300.63% to $3.2 million. Cash position strengthened by 111.15% to $1.47 million, while total assets grew by 82.07% to $7.07 million. Additionally, ETST reduced its outstanding shares by 4.72%, demonstrating commitment to shareholder value.

Earth Science Tech (OTST: ETST) has reported exceptional financial projections for FY ending March 31st, 2025, with projected net income of $3.6 million (340% YoY increase) and revenue of $32 million (175% YoY growth). The company's EPS is projected at $0.01, with total assets reaching $7.2 million (85% growth). Key developments include: expansion of Board to 7 members, qualification for OTCID listing, growth to 76 total employees, and repurchase of 15.6M shares under a $5M program. ETST made strategic acquisitions including Mister Meds, Avenvi, Las Villas Health Care, and Magnefuse. RxCompoundStore expanded to 24 states, while Peaks Curative launched Zoolzy for animal health. The company's subsidiaries span healthcare, real estate, and consumer retail sectors, positioning ETST for continued growth.

Earth Science Tech, Inc. (OTC: ETST) has reported impressive financial results for the quarter ended June 30, 2024. The company, focused on the health and wellness industry, saw significant improvements across key financial metrics compared to the same period in 2023:

Revenue surged to $8,568,918, a 3,796.13% increase from $219,934 in the previous year. Gross profit rose to $6,410,434, up 4,208.99% from $148,769. The company achieved a net profit of $1,076,254, compared to a loss of $35,596 in 2023, marking a 3,123.53% improvement.

ETST's financial position also strengthened, with cash increasing by 1,404.97% to $1,384,407 and total assets growing by 62.04% to $4,772,247. These results demonstrate substantial growth and improved profitability for Earth Science Tech in the health and wellness sector.

Earth Science Tech, Inc. (OTC: ETST) announced its annual financial results for the fiscal year ending March 31, 2024, showcasing significant growth. The company reported $11.95 million in revenue, a remarkable 24,527.88% increase year-over-year (YOY), and a net profit of $812,139 compared to a loss of $365,405 the previous year, marking a 322.26% improvement. The total assets grew by 42.28% to $3.88 million, and cash reserves surged by 1,851.34% to $697,721. The gross profit also saw a substantial rise to $7.83 million, an increase of 35,387.28% YOY. Key operational highlights include the repurchase of 5,200,002 shares, the expansion of office and storage spaces, and enhancement of the Board of Directors with new members and the establishment of an audit committee. Additionally, the company expanded its workforce to 39 employees and 8 independent contractors. RxCompoundStore.com and Peaks Curative, , two of the company's subsidiaries, continue to expand their services and market presence in the health and wellness industry.

Earth Science Tech, Inc. (OTC: ETST) shares an annual letter from the CEO, highlighting significant accomplishments for the fiscal year ending March 31, 2024. The company has made substantial progress in various areas, such as expanding operations, hiring key personnel, repurchasing shares, and achieving impressive revenue growth. These achievements demonstrate management's dedication to shareholder value and strategic growth initiatives.